Table 1.
Sensitivities and specificities of nine rapid antigen testing assays for SARS‐CoV‐2 detection
| Rapid antigen tests | Patient information/disease status | Sample size | Sensitivity | Specificity | Reference |
|---|---|---|---|---|---|
| COVID‐VIRO® | Symptomatic/asymptomatic | 248 | 96.7% | 100% | [3] |
|
Abbott Panbio™ COVID‐19 Ag Rapid Test COVID‐19 Ag ECO Test |
Symptomatic |
44 68 |
100% 82.0% |
94.0% 98.0% |
[4] |
|
Abbott Panbio™ COVID‐19 Ag Rapid Test BioSpeedia COVID19 Speed‐Antigen Test |
Symptomatic/presymptomatic/asymptomatic | 401 |
75.0% 65.5% |
NA 100% |
[5] |
| Abbott Panbio™ COVID‐19 Ag Rapid Test | Children: Symptomatic/asymptomatic | 744 | 82.4% | 100% | [6] |
|
CoV‐Ag Rapid Test Cassette (BioRad) GSD NovaGen COVID‐19 Ag Rapid Test (NovaTec) Aegle CoV‐Ag Rapid Test Cassette (LumiraDx) |
NA | 199 |
62.7% 61.9% 64.0% |
100% 85.7% 100% |
[7] |
| AgPOCT (Roche) |
Symptomatic/asymptomatic (symptomatic) (asymptomatic) |
2375 (1539) (836) |
68.9% (69.5%) (62.0%) |
99.6% (99.5%) (97.6%) |
[8] |
| COVID‐19 Ag Respi‐Strip (Coris BioConcept) | NA | 50 | 30.8% | 100% | [9] |
| Abbott Panbio™ COVID‐19 Ag Rapid Test a | Adult/children; Symptomatic/presymptomatic/asymptomatic | 1145 | 76.3% a | NA | This study |